Xponance Inc. Purchases New Holdings in Hamilton Lane Incorporated (NASDAQ:HLNE)

Xponance Inc. purchased a new stake in shares of Hamilton Lane Incorporated (NASDAQ:HLNE) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 2,215 shares of the company’s stock, valued at approximately $251,000.

Several other large investors also recently modified their holdings of HLNE. Envestnet Asset Management Inc. grew its stake in shares of Hamilton Lane by 40.1% in the 3rd quarter. Envestnet Asset Management Inc. now owns 196,029 shares of the company’s stock valued at $17,729,000 after purchasing an additional 56,115 shares during the period. FMR LLC grew its position in Hamilton Lane by 228.5% during the 3rd quarter. FMR LLC now owns 61,672 shares of the company’s stock worth $5,578,000 after acquiring an additional 42,898 shares during the last quarter. Fiera Capital Corp bought a new stake in Hamilton Lane during the 3rd quarter worth approximately $3,256,000. ClariVest Asset Management LLC bought a new stake in Hamilton Lane during the 3rd quarter worth approximately $2,827,000. Finally, Richard Bernstein Advisors LLC bought a new stake in Hamilton Lane during the 3rd quarter worth approximately $2,774,000. 97.40% of the stock is currently owned by institutional investors.

Hamilton Lane Stock Performance

HLNE stock opened at $114.53 on Friday. The business’s fifty day moving average is $111.80 and its 200-day moving average is $105.76. The company has a quick ratio of 2.58, a current ratio of 2.58 and a debt-to-equity ratio of 0.32. The company has a market cap of $6.19 billion, a P/E ratio of 35.24 and a beta of 1.18. Hamilton Lane Incorporated has a twelve month low of $62.86 and a twelve month high of $121.90.

Hamilton Lane (NASDAQ:HLNE) last posted its quarterly earnings results on Tuesday, February 6th. The company reported $0.71 earnings per share for the quarter, missing analysts’ consensus estimates of $0.88 by ($0.17). The company had revenue of $125.26 million during the quarter, compared to analyst estimates of $130.47 million. Hamilton Lane had a net margin of 25.22% and a return on equity of 28.77%. The business’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period last year, the company earned $0.43 EPS. Equities research analysts forecast that Hamilton Lane Incorporated will post 3.53 EPS for the current year.

Hamilton Lane Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, April 4th. Stockholders of record on Friday, March 15th were paid a $0.445 dividend. This represents a $1.78 dividend on an annualized basis and a dividend yield of 1.55%. The ex-dividend date was Thursday, March 14th. Hamilton Lane’s dividend payout ratio (DPR) is currently 54.77%.

Insider Activity

In other news, major shareholder Oakville Number 2 Trust sold 55,000 shares of the stock in a transaction on Thursday, March 7th. The stock was sold at an average price of $108.00, for a total value of $5,940,000.00. Following the transaction, the insider now owns 480,015 shares of the company’s stock, valued at approximately $51,841,620. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 26.82% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

HLNE has been the topic of a number of research analyst reports. UBS Group increased their price target on Hamilton Lane from $118.00 to $120.00 and gave the stock a “neutral” rating in a research report on Friday, April 12th. Wells Fargo & Company upped their price objective on Hamilton Lane from $106.00 to $111.00 and gave the stock an “equal weight” rating in a report on Wednesday, February 7th. Morgan Stanley upped their price objective on Hamilton Lane from $102.00 to $126.00 and gave the stock an “equal weight” rating in a report on Wednesday, January 24th. JPMorgan Chase & Co. downgraded Hamilton Lane from an “overweight” rating to a “neutral” rating and set a $115.00 price objective on the stock. in a report on Thursday, April 11th. Finally, Oppenheimer downgraded Hamilton Lane from an “outperform” rating to a “market perform” rating in a report on Thursday, January 11th. Six investment analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $109.67.

Hamilton Lane Company Profile

Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.